Exoskeleton Robots - Global Market Trajectory & Analytics

Global Exoskeleton Robots Market to Reach $2.1 Billion by 2026

Robotic exoskeletons are wearable ambulatory machines that rely on mechanical structures, rotors, levers and hydraulics to move stiff body parts and help users in performing routine tasks with high endurance and strength. These external skeletons use artificial intelligence and sensors to detect bio-neurotic signals from the brain and trigger the frame to move in line with specific instructions like sitting, standing or lifting an object. Growth in the global market is being driven by increasing applications across diverse industries, rising geriatric population, technological innovations and broader scope in the military and healthcare sectors. These suits are anticipated to find extensive adoption in healthcare applications and benefit from increasing number of rehabilitation centers. Against the backdrop of strict social distancing measures and travel restrictions to curb spread of the coronavirus, the combination of worker shortage and exponential growth of the e-commerce sector has created a strong demand for advanced tools across diverse industries to boost productivity while ensuring worker safety. The requirement has played an important role in driving the adoption of powered, full-body exoskeletons for production units, construction sites and other complex environments.

Amid the COVID-19 crisis, the global market for Exoskeleton Robots estimated at US$896.4 Million in the year 2022, is projected to reach a revised size of US$2.1 Billion by 2026, growing at a CAGR of 21.2% over the analysis period. Healthcare, one of the segments analyzed in the report, is projected to grow at a 20.8% CAGR to reach US$1.2 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Industrial segment is readjusted to a revised 23.1% CAGR for the next 7-year period. This segment currently accounts for a 30.4% share of the global Exoskeleton Robots market. Healthcare continues to be the primary end-use application segment of the robotic exoskeletons market as a result of increasing adoption of these suits by seniors and people with mobility disorders. Rising acceptance of exoskeletons in rehabilitation centers coupled with increasing incident of spinal cord injuries and associated treatments are bolstering the healthcare segment.

The U.S. Market is Estimated at $384.8 Million in 2022, While China is Forecast to Reach $255.8 Million by 2026

The Exoskeleton Robots market in the U.S. is estimated at US$384.8 Million in the year 2022. The country currently accounts for a 43.07% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$255.8 Million in the year 2026 trailing a CAGR of 25.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.9% and 19.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 21% CAGR while Rest of European market (as defined in the study) will reach US$305.6 Million by the end of the analysis period. Growth in North America region is being driven by major contribution from the US, rising aging population and high purchasing power of people. The market demand is propelled by increasing cases of spinal cord injury and stroke along with associated disabilities. Increasing awareness about these options and regulatory approval for medical exoskeletons are poised to fuel demand, while increasing number of rehabilitation centers to serve people with spinal cord injuries, stroke, traumatic brain surgeries, cerebral palsy and multiple sclerosis are expected to bolster the market. Improvements in healthcare infrastructure, a massive patient pool and government funding for medical devices are the major factors fueling growth in the Asia-Pacific region.

By End-Use, Industrial Segment to Reach $714 Million by 2026

The Industrial segment is gaining from increasing cases of workplace injuries and rising awareness regarding various merits of using exoskeletons in industrial applications. The increasing demand for advanced products to empower workers in different sectors like manufacturing, construction and distribution is poised to benefit the industrial segment. In the global Industrial segment, USA, Canada, Japan, China and Europe will drive the 22% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$167.4 Million will reach a projected size of US$699.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$70.2 Million by the year 2026.

Select Competitors (Total 102 Featured):

• ATOUN Inc.
• Bioness Inc.
• Bionik Laboratories Corp.
• Bioservo Technologies AB
• B-Temia Inc.
• Cyberdyne Inc.
• Ekso Bionics Holdings Inc.
• Gogoa Mobility Robots
• Hocoma AG
• Lockheed Martin Corporation
• Parker-Hannifin Corporation
• RB3D
• Rehab-Robotics Company Limited
• ReWalk Robotics Ltd.
• Rex Bionics Ltd.
• suitX (US Bionics)

What`s New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to the digital archives
• Complimentary updates for one year

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.